drugset / Trial / NCT02283788
Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, double-blind, placebo-controlled and open label active-controlled, 4 period crossover trial to evaluate the effect of eslicarbazepine acetate on cardiac repolarization in healthy adult men and women
Timeline
- Start
- 2007-03
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | — |
| Subject | Eslicarbazepine acetate | Unknown | 2400 mg | — |
| Subject | Moxifloxacin | Small molecule | 400 mg | — |